(Q68205108)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1629628%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Increasing epidermal growth factor receptor expression in human melanocytic tumor progression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1629628%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Increasing Epidermal Growth Factor Receptor Expression in Human Melanocytic Tumor Progression (English)

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

17 October 2022

1 reference

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

17 October 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

17 October 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

17 October 2022

1 reference

P. E. de Wit

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1629628

17 October 2022

S. Moretti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1629628

17 October 2022

P. G. Koenders

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1629628

17 October 2022

M. A. Weterman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1629628

17 October 2022

G. N. van Muijen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1629628

17 October 2022

B. Gianotti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1629628

17 October 2022

D. J. Ruiter

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1629628

17 October 2022

language of work or name

English

0 references

publication date

1 August 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1629628%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 September 2019

https://api.elsevier.com/content/article/PII:S0022202X9290371A?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

https://api.elsevier.com/content/article/PII:S0022202X9290371A?httpAccept=text/plain

17 October 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

Journal of Investigative Dermatology

17 October 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1629628%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1629628%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1629628%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

168-173

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1629628%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1111/1523-1747.ep12616793

22 September 2019

exact match

0 references

cites work

The clonal evolution of tumor cell populations

1

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

Monoclonal antibodies selected to discriminate between malignant melanomas and nevocellular nevi

17 October 2022

2

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

Phenotypic dynamics of tumor progression in human malignant melanoma

17 October 2022

3

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes

17 October 2022

4

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma

17 October 2022

5

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas

17 October 2022

7

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

Specific radiolabeling of a cell surface receptor for epidermal growth factor

17 October 2022

9

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

17 October 2022

10

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

17 October 2022

Epidermal Growth Factor

11

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells

17 October 2022

12

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide

17 October 2022

13

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

A431 cell variants lacking the blood group A antigen display increased high affinity epidermal growth factor-receptor number, protein-tyrosine kinase activity, and receptor turnover

17 October 2022

15

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice

17 October 2022

16

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

Membrane associated antigens of human malignant melanoma V: Serological typing of cell lines using antisera from nonhuman primates

17 October 2022

18

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

Establishment of an ascitic human melanoma cell line that metastasizes to lung and liver in nude mice

17 October 2022

19

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice

17 October 2022

20

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

Nerve growth factor receptors on human melanoma cells in culture

17 October 2022

22

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

17 October 2022

23

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

The efficacy of histopathological criteria required for diagnosing dysplastic naevi

17 October 2022

24

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange

17 October 2022

27

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

17 October 2022

Genomic sequencing

28

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

17 October 2022

29

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene

17 October 2022

30

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

Ligand-induced transformation by a noninternalizing epidermal growth factor receptor

17 October 2022

31

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793

Antireceptor antibodies in the study of EGF-receptor interaction

17 October 2022

32

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12616793